Publications and Scientific Articles

Report on the 2017 FCF Scientific Conference

The distinguished Journal of Hepatocellular Carcinoma has published a report on FCF’s 2017 Scientific Conference. The authors are Drs. Ted Kastenhuber, Ghassan Abou-Alfa, and John Craig who coordinated the writing and editing. FCF thanks these doctors for their time and commitment to this article. The article, which can be viewed here,  is titled, “Road map for fibrolamellar carcinoma: progress and goals of a diversified approach”.

Other Articles on Fibrolamellar

OrderDateTopicAuthorsArticle title and link
1807/2020GenomicsAbou-Alfa, El Dika, Bowman, Berger, et alMolecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver
1796/2020DiagnosticsDu Toit, AlderaFibrolamellar Carcinoma With Predominantly Pseudoglandular Architecture: A Potential Diagnostic Pitfall
1785/2020DiagnosticsChen, de Gonzalez, Fazlollahi, et alIn situ hybridisation for albumin RNA in paediatric liver cancers compared with common immunohistochemical markers
1775/2020Clinical TrialEl Dika, Mayer, Abou-Alfa, Capanu, et alA Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT ) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma
1765/2020Case reportLemekhova, Hornuss, Polychronidis, et alClinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
1754/2020PathwaysDinh, SethupathyHotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities
1743/2020Clinical TrialAbou-Alfa, Mayer, Gordan, Venook, et alPhase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
1732/2020ModelingDe Oliviera, HuttenlocherDnaJ-PKAc fusion induces liver inflammation in a zebrafish model of Fibrolamellar Carcinoma
1722/2020DiagnosticsDong, Wang, Mao, Zhang, et alImaging Features of Fibrolamellar Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound
1712/2020Case reportRamai, Ofosu, Lai, Gao, et alFibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study
1701/2020OutcomesAssi, Mukherjee, Macchiorlatti, et alPredictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database
1691/2020DiagnosticsAnysz-Grodzicka, Podgorska, CieszanowskiState-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellular cholangiocarcinoma
1681/2020GenomicsDinh, Sritharan, Smith, et alHotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
16712/2019GenomicsHirsch, Negulescu, Gupta, et alBAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
16611/2019Case ReportBalbeur, BrichardDNAJB1‐PRKACA–positive metastatic fibrolamellar carcinoma with unknown primary in a pediatric patient
16511/2019GenomicsVyas, Hechtman, Zhang, Benayed, et alDNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma
16410/2019TargetsJewell, Gibson, Guy, et alSingle-Cell RNA Sequencing Identifies Yes-Associated Protein 1–Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma
1639/2019ModelingDe Oliviera, Huttenlocher, et al DNAJB1-PRKACA fusion induces liver inflammation in zebrafish model of Fibrolamellar Hepatocellular Carcinoma
1629/2019PrognosticsLafaro, Eng, Raoff, Melstrom, et alA prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinom
1619/2019PathwaysRiehle, Kenerson, Riggle, et alNeurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma
1607/2019PathwaysKarki, Putra, Kim, Laquaglia, et alMDM4 expression in fibrolamellar hepatocellular carcinoma
1596/2019Case ReportBauer, Mogler, Braren, et alProgression after Immunotherapy for Fibrolamellar Carcinoma
1586/2019Case ReportChalkrabarti, Tella, Kommalapati, et alClinicopathological features and outcomes of fibrolamellar
hepatocellular carcinoma
1575/2019Case ReportCho, Chen, Paludo, Conboy, et alHyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review
1565/2019GenomicsTurnham, Smith, Kenerson, Omar, et alAn acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
1554/2019
OverviewKastenhuber, Ramsey, Sullivan, Sage, et alRoad map for fibrolamellar carcinoma: progress and goals of a diversified approach
1543/2019PathwaysKim, Gani, Layman. Besharati, et alMultiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
1531/2019GenomicsDinh, Jewell, Kranke, Scott, DiehlMicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma
1521/2019Case ReportSuarez, Perez, Garzon, Daza, et alFibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
15111/2018ReviewChaudhari, Khobragade, Bhandare, ShrikhandeManagement of fibrolamellar hepatocellular carcinoma
1509/2018ReviewLin, YangFibrolamellar Carcinoma: A Concise Review
1498/2018Case ReportTanaka, Hijioka, Iwaya, Mizuno, et alFibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy
1488/2018Case ReportBartlett, Leslie, Gupta, GellerAcquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma
1476/2018RadiologyGaneshan,Szklaruk, Kaseb, Kattan, ElsayesFibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases
1466/2018Case ReportShah, Kamboj, ClearyLarge Hepatic Mass in an Adolescent Male
1456/2018PathologyGrahamFibrolamellar Carcinoma What Is New and Why It Matters
1444/2018Case ReportInce, Isik, Ozdemir, et alLiving-Donor Liver Transplant for Fibrolamellar Hepatocellular Carcinoma With Hilar Lymph Node Metastasis: A Case Report
1433/2018GenomicsFarber, Lalazar, Simon, Hammond, et alNon coding RNA analysis in fibrolamellar hepatocellular carcinoma
1422/2018RadiologyPalm, Sheng, Mayer, Weiss, et alImaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acidenhanced MR
1412/2018ReviewLalazar, SimonFibrolamellar Carcinoma: Recent advances and unresolved questions on the molecular mechanisms
1402/2018Case ReportMafeld, French, Tiniakos, et alFibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resectio
1392/2018Case ReportBill, Montani, Blum, Dufour, et alFavorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver
1381/2018GenomicsTomasini, Wang, Simon, et alConformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma
13712/2017TargetingStratakisCyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA ): the expected, the unexpected, and what might be next
13612/2017Case ReportHammond, Lalazar, Saltsman, et alIntracranial Metastasis in Fibrolamellar Hepatocellular Carcinoma
13512/2017GenomicsGraham, Lackner, Terracciano, et alFibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion
13411/2017GenomicsKastenhuber, Lalazar, Houlihan, et alDNAJB1–PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
13310/2017RadiologySemelka, Nimojan, Chandana, Ramalho, et alMRI features of primary rare malignancies of the liver: A report from four university centres
1329/2017GenomicsKastenhuber, Lalazar, Houlihan, Tschaharganeh, et alDNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
1319/2017ModelingEngelholm, Riaz, Serra, et alCRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1–Prkaca Gene Fusion is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
1309/2017DiagnosticsGraham, Yeh, Lam-Himlin, Roberts, et alMolecular testing for the clinical diagnosis of fibrolamellar carcinoma
1298/2017TargetingCooney, Wei, RangaswamiCD47 is not Over-Expressed in Fibrolamellar Hepatocellular Carcinoma
1286/2017SEER StudyNautsch, Ludwig, Xing, Johnson, KimRacial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer A Surveillance, Epidemiology, and End Results (SEER) Population Study
1275/2017Case ReportCiurea, Matei, Stanescu, Lupescu, et alFibrolamellar hepatocellular carcinoma with ovarian metastasis - an unusual presentation
1265/2017GenomicsSorenson, Khanin, Bamboat, Cavnar, et alGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation
1255/2017Case ReportAndrade, de Lima, de Faria, VargasTP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
1243/2017PathologyKim, Rhee. Yoo. Alves, et alTumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma
1233/2017Case ReportVishnu, Kulkarni, Vidhyalakshmi, et alFibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas
1223/2017GenomicsDinh, Vitucci, Wauthier, Graham, et alComprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
1213/2017ReviewWahab, Hanafy, Nakeeb, AliClinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period)
1203/2017Case ReportSurjan, dos Santos, Basseres, Makdissi, MachadoA Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation
1193/2017Case reportGraham, Craig, Jin, Olivera, et alEnvironmental exposures as a risk factor for fibrolamellar carcinoma
1181/2017ReviewGraham, TorbensonFibrolamellar carcinoma: A histologically unique tumor with unique molecular findings
11712/2016Case ReportHernandez, Ruiz, TorreDuodenalRecurrenceofFibrolamellarCarcinoma12Years AfterPartialHepatectomyandAdjuvantChemotherapy
11611/2016TreatmentsAtienza, Berger, Mei, Shah, et alLiver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective
11511/2016Case ReportAlsina, Franco, Nakshabandi, et alSuccessfulLiverTransplantationforHyperammonemic FibrolamellarHepatocellularCarcinoma
1148/2016Case ReportDiez, Higueras, Zafra, et alFibrolamellar hepatocellular carcinoma: a rare entity diagnosed by abdominal ultrasound
1137/2016ReviewYamashita, Vauthry, Kaseb, Aloia, et alPrognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma
1125/2016ReviewKassahunContemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments
1115/2016Case ReportBernieh, Adams, Liu, Flowers, et alFibrolamellar hepatocellular carcinoma in ascitic fluid: A case report with cytohistological correlation
1104/2016Case StudyGriffith, Griffith, Krysiak, Magrini, et alAgenomiccasestudyofmixed fibrolamellar hepatocellularcarcinoma
1093/2016PathwaysRiggle, Riehle, Kenerson, Turnham, et alEnhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
1083/2016ReviewRiggle, Turnham, Scott, Yeung, et alFibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
1073/2016Case reportChapuy, Sahai, Sharma, Zhu, KozyrevaHyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm
1062/2016DiagnosticsSergiHepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer
10512/2015Case ReportLimaiem, Bouraoui, Sboui, Lahmar, et alFibrolamellar carcinoma versus scirrhous hepatocellular carcinoma : diagnostic usefulness of CD68
10411/2015SEER StudyLau, Mahendraraj, ChamberlainHepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011)
10311/2015SEER StudyJernigan, Wima, Hanseman, Hoehn, et alNatural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry
10210/2015ModelingPatmanA model of fibrolamellar carcinoma
10110/2015GenomicsSimon, Freije, Farber, Lalazar, et alTranscriptomic characterization of fibrolamellar hepatocellular carcinoma
10010/2015GenomicsReid, SethupathyThe DNAJB1‐PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas
9910/2015ModelingOikawa, Wauthier, Dinh, Selitsky, et alModel of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
989/2015Case ReportVilla, Pannala, Faigel, Haakinson, et alMetastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
978/2015GenomicsGraham, Garcia, Griepp,Barr Fritcher, Kipp, TorbensonFGFR1 and FGFR2 in fibrolamellar carcinoma
968/2015GenomicsMalouf, Tahara, Paradis, Fabre, et alMethylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive feature
955/2015Case ReportChagas, Kikuchi, Herman, Alencar, et alClinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
944/2015Case ReportAroraFibrolamellar Hepatocellular Carcinoma Presenting as Obstructive Jaundice: Uncommon Presentation of a Rare Entity
934/2015EditorialAndersenFibrolamellar Hepatocellular Carcinoma: A Rare but Distinct Type of Liver Cancer
922/2015GenomicsGraham, Jin, Knutson, Kloft-Nelson, et alDNAJB1-PRKACA is specific for fibrolamellar carcinoma
911/2015GenomicsCornella, Alsinet. Sayols, Zhang, et alUnique genomic profile of fibrolamellar hepatocellular carcinoma
901/2015GenomicsDarcy, Chiaroni-Clarke, Murphy, et alThe genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients
891/2015PrognosticsDarcy, Malek, Kobos, et alPrognostic factors in fibrolamellar hepatocellular carcinoma in young people
8812/2014ReviewLim. Farber, LaQuagliaAdvances in fibrolamellar hepatocellular carcinoma: a review
8712/2014TreatmentsHerman, Chagras, Perini, Coelho, et alSurgical treatment of fibrolamellar hepatocellular carcinoma: an underestimated malignant tumor?
868/2014GenomicsXu, Hazard, Zmoos, Jahchan, et alGenomic analysis of fibrolamellar hepatocellular carcinoma
857/2014Case ReportSulaiman, GeberhiwotFibrolamellar Hepatocellular Carcinoma Mimicking Ornithine Transcarbamylase Deficiency
847/2014Case ReportFonseca, Varella, Coelho, Abe, et alDownstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma
836/2014SignallingRiehle, Yeh, Yu, Kenerson, et almTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma
826/2014SEER StudyEggert, McGlynn, Duffy, Manns, et alFibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results databas
816/2014Case ReportChiarelli, De Simone, Guttadauro, CioffiFibrolamellar carcinoma in a 62 year-old patient with human immunodeficiency virus infection
806/2014DiagnosticsDo, McErlean, Ang, et alCT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients
795/2014ReviewGroeschl, Miura, Wong, Bloomston, et alMulti‐institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma
783/2014Case ReportOkur, Eser, Yilmaz, Dalgic, et alSuccessful Multimodal Treatment for Aggressive Metastatic and Recurrent Fibrolamellar Hepatocellular Carcinoma in a Child
772/2014GenomicsHoneyman, Simon, Robine, Clarke, et alDetection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
762/2014DiagnosticsGaneshan, Szklaruk, Kundra, Kaseb, et alImaging Features of Fibrolamellar Hepatocellular Carcinoma
751/2014GenomicsMalouf, Job, Paradis, Fabre, et alTranscriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature
741/2014SEER StudyBasileLong-term Survival of Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A US Population-based Study
731/2014ReviewAllan, Wang, Davis, et alA review of 218 pediatric cases of hepatocellular carcinoma
7212/2013ReviewMayo, Mavros, Nathan, et alTreatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective
7111/2013Case ReportPeacock, Call, OlivierRadiotherapy for metastatic fibrolamellar hepatocellular carcinoma
709/2013ReviewKaseb, Sharma, Sahin, Nooka, et alTreatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma
698/2013Case ReportMinutolo, Licciardello, Arena, Minutolo, et alSurgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
687/2013Case ReportDe Gaetano, Nure, Grossi, Frongillo, et alFibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association
677/2013Case ReportMatsuda, Amemiya, Kawaida, Okamoto, et alTypical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case
667/2013ReviewKaseb, Sharma, Sahin, Nooka, et alPrognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma
655/2013EpidemiologyEggert, McGlynn, Duffy, Manns, et alEpidemiology of fibrolamellar hepatocellular carcinoma in the U.S., 2000–2010
645/2013ReviewWeeda, Murawski, McCabe, et alFibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
635/2013Case ReportFakihA Case of Fibrolamellar Cancer With a Palliative Response and Minor Radiographic Regression With Erlotinib and Bevacizumab Combination Therapy
623/2013ReviewAng, Kelley, Choti, Cosgrove, et alClinicopathologic Characteristics and Survival Outcomes of Patients With Fibrolamellar Carcinoma: Data From the Fibrolamellar Carcinoma Consortiu
611/2013Case ReportSingh, RamakrishnaCombined Hepatocellular Carcinoma and Fibrolamellar Carcinoma Presenting as Two Adjacent Separate Lesions in a Young Boy: First Case Report from Asia
6010/2012Case ReportBerger, Dimant, Hermida, Paulin, et alHyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma
599/2012ReviewMavros, Mayo, Hyder, et alA Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
588/2012GenomicsPatonai, Erdelyi-Belle, Korompay, et alMolecular Characteristics of Fibrolamellar Hepatocellular Carcinoma
573/2012Case reportGras, Truant, Boige, Ladrat, et al Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
563/2012Case ReportKnudson, Goldberg, AyresFibrolamellar hepatocellular carcinoma with cardiac spread causing severe inferior vena cava obstruction in a 9-year-old child
553/2012ReviewMalouf, Brugieres, Le Deley, Faivre, et alPure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection
542/2012Case ReportBenito, Segura, Martinez. et alFibrolamellar hepatocellular carcinoma metastatic to the ovary
531/2012Case reportKo, Verhoeven, Lee, Corbin, Vogl and PedersenA Translational Study "Case Report" on the Small Molecule "Energy Blocker" 3Bromopyruvate (3BP) as a Potent Anticancer Agent: From Bench Side to Bedside
521/2012MechanismsWilczek, Szparecki, Lukasik, KoperskiLoss of the Orphan Nuclear Receptor SHP Is More Pronounced in Fibrolamellar Carcinoma than in Typical Hepatocellular Carcinom
511/2012ReviewTorbensonFibrolamellarCarcinoma:2012Update
505/2011Case ReportMuramori, Taguchi, Taguchi, Kohashi, et alHigh Aromatase Activity and Overexpression of Epidermal Growth Factor Receptor in Fibrolamellar Hepatocellular Carcinoma in a Child
494/2011MarkersPatonai, Erdelyi-Belle, Korompay, Somoracz, et alClaudins and tricellulin in fibrolamellar hepatocellular carcinoma
484/2011Case ReportLiu, Chan, Tong, Wang, et alPET–CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature
472/2011ReviewWard, WaxmanFibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors
4612/2010ReviewDhingra, Li, Tan, Zenali, et alCell cycle biology of fibrolamellar hepatocellular carcinoma
4511/2010GenomicsRoss, Daniel, Vivekanandan, Kannangai, et alFibrolamellar Carcinomas are Positive for CD68
4411/2010MarkersLidballe, Nguyen, Poulsen, et alHaptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
4311/2010GenomicsTrankenschuh, Puls, Christgen, Albat, et alFrequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver
425/2010ReviewWard, Huang, Tickoo, ThungFibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
415/2010ComparativeAbdul-Al, Wang, MahkloufFibrolamellar Hepatocellular Carcinoma: An Immunohistochemical Comparison With Conventional Hepatocellular Carcinoma
404/2010ComparativeZenali, Tan, Li, Dhingra, BrownStemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma
393/2010Genomics Vivekanandan, Daniel, Yeh, TorbensonMitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
383/2010PathwaysLi, Tan, Zenali, BrownConstitutive activation of nuclear factor-kappa B (NF-κB) signaling pathway in fibrolamellar hepatocellular carcinom
372/2010Case ReportBhanjee, Locketz, KrigeFibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series
3612/2009Case ReportSethi, Tageja, Dave, et alHyperammonemic Encephalopathy: A Rare Presentation of Fibrolamellar Hepatocellular Carcinoma
3512/2009Case ReportTerzis, Haritanti, EconomouFibrolamellar Hepatocellular Carcinoma: a Case Report with Distinct Radiological Feature
347/2009ReviewLiu, Chan, Wang, QiaoFibrolamellar hepatocellular carcinoma
337/2009Case ReportButte, Waugh, Meneses, Pruzzo, et alFibrolamellar liver carcinoma: report of two cases and review of the literature
3111/2008GenomicsKakar, Chen, Ho, Burgart, et alChromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization
3011/2008Genomics Vivekanandan, Shien, TorensonAnterior Gradient-2 is Over Expressed by Fibrolamellar Carcinomas
293/2008Case ReportSmith, Blatt, Jedicka, Strain, FentonFibrolamellar Hepatocellular Carcinoma
282/2008GenomicsVivekanandan, TorensonEpigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas
275/2007Case ReportMeriggi, ForniSurgical therapy of hepatic fibrolamellar carcinoma
264/2007ReviewTorbensonReview of the Clinicopathologic Features of Fibrolamellar Carcinoma
253/2007GenomicsKannangai, Vivekanandan, Martinez-Murillo, Choti, et alFibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways
185/2005PathologyKakar, Burgart, Batts, Gacia, et alClinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis
102/2003Clinical trialPatt, Hassan, Lozano, Brown, et alPhase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma
911/2002GuidelinesRyderGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
17/1988Case reportBerman, Burnhamet and SheahanFibrolamellar carcinoma of the liver: An immunohistochemical study of nineteen cases and a review of the literature
2110/2005Case ReportImkie, Myers, Li, Fan, et alFibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases
2010/2005Case ReportZermani, Charfi, Kourda, Farah, et alA particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant
199/2005PathologyKlein, Molmenti, Colombani, Grover, et alPrimary Liver Carcinoma Arising in People Younger Than 30 Years
185/2005PathologyKakar, Burgart, Batts, Gacia, et alClinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis
1712/2004PathwaysSahin, Kannangai, Adegbola, Wang, et almTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms
168/2004Case ReportKanai, Takabayashi, Kawano, et alA Case of Postoperative Recurrence of Fibrolamellar Hepatocellular Carcinoma with Increased Vitamin B12 Binding Capacity in a Young Japanese Female
153/2004DiagnosticsVasdev, NayakCD99 expression in hepatocellular carcinoma: an immunohistochemical study in the fibrolamellar and common variant of the tumour
143/2004SEER StudyEl-Serag, DavilaIs fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study
131/2004Case ReportTerracciano, Tornilla, Avoledo, et alFibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis
1212/2003Case ReportKitabayashi, Yokoi, Ueno, Saito, et alFibrolamellar hepatocellular carcinoma: report of a case
114/2003ReviewKatzenstein, Krailo, Malogolowkin, Ortega, et alFibrolamellar hepatocellular carcinoma in children and adolescents
102/2003Clinical trialPatt, Hassan, Lozano, Brown, et alPhase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma
911/2002GuidelinesRyderGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
88/2002ReviewArista-Nasr, Gutierrez-Villalobos, Nuncio, Maldonato, et alFibrolamellar hepatocellular carcinoma in mexican patients
71/2002DiagnosticsWang, Cui, YuImaging findings of fibrolamellar hepatocellular carcinoma
66/2001GenomicsSirivatanauksorn, Sirivatanauksorn, Lemoine, Williamson, DavidsonGenomic homogeneity in fibrolamellar carcinomas
55/2001Case ReportBraune, Frangmann, Scheumann, KlempnauerMultiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient
45/2001GenomicsWilkins, Bredt, Flemming, Kubicka, et alCytogenetic Aberrations in Primary and Recurrent Fibrolamellar Hepatocellular Carcinoma Detected by Comparative Genomic Hybridization
312/2000ReviewEl-Gazzaz, Wong, El-Hadary, Gunson, et alOutcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma
29/2000DiagnosticsIchikawa, Federle, Grazioli, MarshFibrolamellar Hepatocellular Carcinoma: Pre- and Posttherapy Evaluation with CT and MR Imaging
17/1988Case reportBerman, Burnhamet and SheahanFibrolamellar carcinoma of the liver: An immunohistochemical study of nineteen cases and a review of the literature